GlassScriptPhysician profile
Nasser I Youssef
NPI 1063490860
$3,584.95
in general payments reported to CMS, 2019-2025
15 companies · $839 in 2025
The $839 reported for 2025 was more than what a typical Transplant Surgery provider received nationally (typical 2025 total: $423).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $371 · 2020: $163 · 2021: $206 · 2022: $714 · 2023: $692 · 2024: $600 · 2025: $839.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,597 · Travel and Lodging: $534.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,596.79 |
| Travel and Lodging | $534.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Peripheral Vascular, INC. | $1,026.84 | 2019-2024 | Covera |
| Lemaitre Vascular, INC. | $990.68 | 2022-2025 | Anastoclip Gc 8cm (Medium), Artegraft Vascular Graft, Restoreflow |
| Transmedics, INC. | $534.42 | 2025 | Organ Care System |
| Baxter Healthcare | $258.29 | 2023-2025 | Floseal |
| Haemonetics Corporation | $196.25 | 2022-2024 | Teg6s Hemostasis System |
| Medtronic, INC. | $158.40 | 2022 | |
| Boston Scientific Corporation | $116.55 | 2024 | Exalt Model D |
| Genzyme Corporation | $99.13 | 2019 | |
| Ethicon US, LLC | $92.11 | 2022 | |
| Atricure, INC. | $26.96 | 2022 | |
| Depuy Synthes Sales INC. | $23.27 | 2022 | |
| Alnylam Pharmaceuticals INC. | $18.30 | 2023 | Onpattro |
| Veloxis Pharmaceuticals, INC. | $14.99 | 2019 | |
| Smith+Nephew, INC. | $14.54 | 2020 | |
| Vifor Pharma, INC. | $14.22 | 2025 | Veltassa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nasser Youssef listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.